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Abstract 
Medical device-associated infections present a leading global healthcare challenge, 
and effective strategies to prevent infections are urgently required.  Herein, we 
present an innovative anti-adherent hydrogel copolymer as a candidate catheter 
coating with complementary hydrophobic drug-carrying and eluting capacities.  The 
amphiphilic block copolymer, Poloxamer 188, was chemically-derivatized with 
methacryloyl moieties and copolymerized with the hydrogel monomer, 2-
hydroxyethyl methacrylate.  Performance of the synthesized copolymers was 
evaluated in terms of equilibrium swelling, surface water wettability, mechanical 
integrity, resistance to encrustation and bacterial adherence, and ability to control 
release of the loaded fluoroquinolone antibiotic, ofloxacin.  The developed matrices 
were able to provide significant protection from fouling, with observed reductions of 
over 90% in both adherence of the common urinary pathogen Escherichia coli and 
encrusting crystalline deposits of calcium and magnesium salts relative to the 
commonly employed hydrogel, poly(hydroxyethyl methacrylate).  Additionally, the 
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release kinetics of a loaded hydrophobic drug could be readily tuned through facile 
manipulation of polymer composition.  This combinatorial approach shows 
significant promise in the development of suitable systems for prevention of catheter-
associated infections. 
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1. Introduction 
Implanted medical devices are of increasing importance within current clinical 
applications (Gilmore and Carson 2015).  The susceptibility of such implants to 
infection, however, represents a global healthcare challenge with associated patient 
morbidity and potentially fatal outcomes (Cloutier, et al. 2015; Francolini, et al. 2014).  
In this regard, bacterial colonization of urinary catheters, which are inserted in up to 
one quarter of hospitalized patients to drain urine from their bladders (Daniels, et al. 
2014), represents a particular concern.  Catheter-associated urinary tract infections 
(CAUTIs) are responsible for 40% of all nosocomial infections and in excess of 
100,000 hospital admissions in the US per annum (Fisher, et al. 2015).  Furthermore, 
the burden of CAUTIs from a financial perspective has increased significantly on 
account of the recent decision by the US Centers for Medicare and Medicaid Services 
to cease funding treatment of these ‘reasonably preventable’ nosocomial infections 
(Greene, et al. 2014). 
Multiplication of adherent organisms with subsequent biofilm formation and seeding 
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of the bladder mucosa and urine by planktonic bacteria make treatment of medical 
device-associated infections particularly challenging (Daniels, et al. 2014).  Much 
research is now directed towards the development of preventative strategies, such as 
anti-fouling device coatings, to prevent bacterial attachment (Cloutier, et al. 2015).  
Antimicrobial-eluting coatings based on antibiotics, metals or antiseptics, such as 
gentamicin, silver and gendine respectively, have been the subject of significant 
research (Cloutier, et al. 2015; Jamal, et al. 2015; Wang, et al. 2015).  To-date, 
however, issues surrounding the emergence of resistant microorganisms, potential 
selection of non-sensitive strains, toxicity to host cells and the limited antibacterial 
loading capacity of surface coatings have restricted their widespread clinical 
employment (Cloutier, et al. 2015; Coad, et al. 2016). 
Alternatively, non-release-based approaches, such as surface functionalization with 
hydrophilic polymers such as polyethylene glycol, have demonstrated promising 
antifouling ability in vitro (Wei, et al. 2014).  The presence of a tightly-bound water 
layer on the polymer surface in combination with dynamic movement of the outward-
projecting polymer chains effectively hinder attachment of bacterial cells by acting as 
physical and steric barriers (Francolini, et al. 2014; Gultekinoglu, et al. 2015; 
Rodriguez-Emmenegger, et al. 2015).  Their efficacy in resisting bacterial 
colonization and ultimate biofilm development in vivo, however, is ultimately 
compromized by the non-specific and rapid coverage of the device surface with a 
layer of proteins and other cellular matter (Cloutier, et al. 2015). 
The aim of this study was to provide a novel and effective approach for optimizing 
the anti-fouling ability of a passive anti-adherent hydrophilic polymer surface, as a 
candidate coating for infection-resistant medical devices, namely through pairing with 
active agent release to provide a “belt and braces” dual approach to disfavor biofilm 
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establishment.  The effect of chemical modification with an amphiphilic block 
copolymer, Poloxamer 188, on surface water wettability, swellability, tensile 
properties, encrustation and bacterial resistance of the biocompatible hydrogel, 
poly(hydroxyethyl methacrylate) (p(HEMA)), was first of all investigated.  This was 
subsequently followed by examination of the capacity of the candidate device coating 
materials synthesized herein for incorporation and subsequent release of the broad-
spectrum fluoroquinolone antibiotic, ofloxacin.  
 
 
2. Materials and methods 
2.1. Materials 
All materials were of analytical grade or higher and were used as supplied.  2,2’-
Azobisisobutyronitrile (AIBN) was obtained from Acros Organics (Leicestershire, 
UK).  Methacryloyl chloride, dichloromethane (DCM), triethylamine, 2-hydroxyethyl 
methacrylate (2-HEMA), benzalkonium chloride, ofloxacin and urease (Type IX; Jack 
Bean) were purchased from Aldrich (Dorset, UK).  Poloxamer 188 (Lutrol® F68) was 
obtained from BASF (Ludwigshafen, Germany).  Pyridine, magnesium chloride 
hexahydrate, calcium chloride hexahydrate, potassium dihydrogen orthophosphate 
and urea were obtained from BDH Laboratories (Dorset, UK).  Mueller-Hinton agar 
and Mueller-Hinton broth were purchased from Oxoid (Basingstoke, UK). 
 
2.2. Methods 
Poloxamers are a series of amphiphilic, non-ionic block copolymers with a central 
hydrophobic poly(propylene oxide) (PPO) segment flanked by two poly(ethylene 
oxide) (PEO) chains (Kaizu and Alexandridis 2015).  When in solution at 
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concentrations above a critical micelle concentration, the molecules aggregate in a 
process driven by hydrophobic interactions of the PPO blocks (Li and Zhang 2016).  
The inner hydrophobic PPO cores of the resulting micellar structures have been 
exploited for the loading and release of hydrophobic drugs (Li, et al. 2015), and the 
shielding of toxic drugs until their release at targeted tissue sites (Movassaghian, et al. 
2015).  In addition to their high solubilizing capacity and low toxicity, the 
conformational flexibility of the outer hydrophilic corona of PEO chains functions to 
repel approaching bacteria and other particulate matter from the surface (Zeng, et al. 
2014).  In this study, we first of all functionalized Poloxamer 188 molecules with 
methacryloyl moieties to yield polymerisable derivatives for copolymerisation with 
the hydrogel monomer, 2-HEMA.  By controlling the stoichiometric mass of 
methacryloyl chloride added to the reaction mixture, poloxamer moieties could be 
modified at one terminal hydroxyl group (monomethacrylation) or at both terminal 
hydroxyl positions (dimethacrylation) to additionally facilitate functioning of the 
poloxamer derivative as a crosslinker. 
 
2.2.1. Synthesis of mono- and dimethacrylated Poloxamer 188 (MMP and DMP) 
Components were added to a glass round-bottomed flask in the amounts stated in 
Table 1 according to the following procedure.  Poloxamer 188 was dissolved in DCM 
(275 mL for monomethacrylation; 175mL for dimethacrylation) and triethylamine.  
After cooling to 0°C over an ice bath, a solution of methacryloyl chloride in DCM (25 
mL for monomethacrylation; 40 mL for dimethacrylation) was added dropwise with 
stirring.  The ice bath was then removed and the solution stirred for a further 24 h 
before filtration, evaporation of the solvent and washing with deionized water to yield 
a white solid.  
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Table 1: Component masses (g, mmoL) employed for mono- and dimethacrylation of 
Poloxamer 188 
Chemical Mass for 
monomethacrylation (g, 
mmoL) 
Mass for dimethacrylation 
(g, mmoL) 
Poloxamer 188 67.3, 7.8 42.07, 4.89 
Triethylamine 0.14, 1.01 1.4, 10.06 
Methacryloyl chloride 0.1, 1.03  0.95, 9.78 
 
Following synthesis, elucidation of monomer structure was performed using FTIR 
spectroscopy.  Samples were prepared as KBr discs, and spectra recorded on a Jasco 
FTIR-4100 spectrometer between 4000 and 400 cm-1.  Success of the reaction was 
confirmed by the presence of a new band at 1717 cm-1 in spectra of the MMP and 
DMP reaction products, attributed to the newly formed carbonyl ester moiety.  
 
2.2.2. Preparation of poly(monomethacrylated poloxamer-co-hydroxyethyl 
methacrylate) (p(MMP-co-HEMA)) copolymers 
P(MMP-co-HEMA) copolymers containing MMP in weight ratios of 1%, 5% and 
10% relative to the content of HEMA were prepared by the respective addition of 
0.755 g, 3.775 g and 7.55g of the MMP reaction product (comprising 0.1 g, 0.5 g and 
1.0 g of MMP, respectively, and unreacted Poloxamer 188) to 2-HEMA (10 g) and 
AIBN (0.05 g) with stirring.  Following dissolution, mixtures were injected into 
moulds comprising two vertical glass plates lined with release liner, separated by 
silicone tubing and clamped together by bulldog clips.  The polymers were cured at 
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60°C for 18 h, then soaked in successive volumes of deionized water to remove 
unreacted poloxamer.  The amount of poloxamer leaching from the films was 
determined as a function of time by evaporation of the MMP-HEMA rinsing solutions 
and, when no further poloxamer leached from the synthesized films, polymers were 
stored in their hydrated state prior to testing. 
 
2.2.3. Preparation of poly(dimethacrylated poloxamer-co-hydroxyethyl 
methacrylate) (p(DMP-co-HEMA)) copolymers 
P(DMP-co-HEMA) copolymers containing DMP in weight ratios of 1%, 5% and 10% 
relative to the content of HEMA were prepared by the respective addition of 0.1 g, 0.5 
g and 1.0 g DMP to 2-HEMA (10 g) and AIBN (0.05 g) with stirring.  Following 
dissolution, mixtures were injected into moulds, as described for the p(MMP-co-
HEMA) copolymers, and cured at 60°C for 18 h.  Copolymers were then washed in 
successive volumes of deionized water over a 48 h period and stored in their hydrated 
state until testing.  
 
2.2.4. Preparation of poly(hydroxyethyl methacrylate) (p(HEMA)) control 
A control p(HEMA) polymer was prepared by mixing 2-HEMA (10 g) and AIBN 
(0.05 g) with stirring, injecting into moulds and curing at 60°C, as described for the 
copolymers.  Again, the polymers were washed with successive volumes of water 
over a 48 h period and stored in their hydrated state until testing.   
 
2.2.5. Preparation of non-methacrylated poloxamer-loaded poly(hydroxyethyl 
methacrylate) ((NMP-loaded p(HEMA)) 
P(HEMA) polymers loaded with non-methacrylated poloxamer (NMP) in a mass 
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approximating the mass of unreacted poloxamer remaining within 5% p(MMP-co-
HEMA) copolymers after the rinsing step were prepared by dissolving Poloxamer 188 
(3.275 g) and AIBN (0.05 g) in 2-HEMA (10 g).  Solutions were injected into glass 
plate moulds and following polymerization, the films were washed as previously 
described.  
 
2.2.6. Polymer characterisation 
2.2.6.1. Equilibrium water content 
Swollen polymer samples (2 cm x 1 cm) were dried at room temperature and residual 
water subsequently removed by freeze-drying (Modulyo freeze dryer F101-01-000).  
Samples were weighed, immersed in deionized water, and then reweighed at hourly 
intervals, following removal of excess surface water with a lens tissue, until a 
constant mass was achieved.  The equilibrium water content (EWC), defined as the 
ratio of the mass of water in the hydrated sample to the dry sample mass, was 
calculated according to the following equation: 
 
EWC (%) = (Hydrated sample mass – Dry sample mass)/Dry sample mass x 100 
 
2.2.6.2. Contact angle analysis 
Advancing and receding dynamic contact angles of all synthesized polymers were 
determined by the Wilhelmy plate technique using a Dynamic Contact Angle 
Analyser (DCA 312, Cahn Instruments), as previously described (Jones, et al. 2002).  
Briefly, samples (3 cm x 1 cm) were attached to a microbalance and immersed into, 
and withdrawn from, HPLC-grade water at a rate of 150 μms-1.  The wetting force at 
the solid/liquid/vapour interface was automatically recorded as a function of 
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immersion depth and time by a Cahn electrobalance and converted into advancing and 
receding contact angles by the instrument software. 
 
2.2.6.3. Tensile analysis 
Tensile analysis of the synthesized polymers was performed using a Stable Micro 
Systems TA-XT2 Texture Analyser (Goldaming, Surrey, UK), as previously 
described (Jones, et al. 2002).  Hydrated dumbbell-shaped polymer samples (6 cm x 1 
cm) were fixed between lower (static) and upper (moveable) clamps, spaced at a 
distance of 5 cm.  The upper clamp was vertically raised at a constant crosshead speed 
of 0.5 mms-1 until fracture of the film occurred.  Ultimate tensile strength and 
Young’s modulus were calculated from the resultant plot of stress versus strain using 
the following equations: 
 
Ultimate tensile strength (Pa) = Force at break (N)/Cross-sectional area (m2) 
 
Young’s modulus = Tensile stress (Pa)/Strain  
 
2.2.6.4. Calcium and magnesium encrustation 
Polymer discs (8 mm diameter) were mounted onto needles secured to the lid of a 
plastic vessel (1 L) containing artificial urine with a similar composition to that 
employed by Tunney et al. (1996), but with a reduced concentration of albumin 
(Tunney, et al. 1996).  Solutions A (450 mL), B (450 mL) and C (57 mL), the 
compositions and storage conditions of which are shown in Table 2, were added to the 
reaction vessel separately to prevent precipitation of brushite (CaHPO4.2H2O). 
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Table 2: Composition of artificial urine 
Solution Component (% w/v) Storage conditions 
A 
 
Potassium 
dihydrogen 
orthophosphate 
0.76 
 
Room temperature 
 
Magnesium 
chloride 
hexahydrate 
0.36 
 
Urea  1.0 
B 
 
Calcium chloride 
hexahydrate 
0.53 
 
4°C 
 
Chicken ovalbumin 0.04 
C Jack bean urease 
(Type IX) 
0.125 4°C 
 
 
The vessel was shaken in an orbital incubator (100 rpm, 37°C) to simulate conditions 
in the bladder, and artificial urine solution (140 mL) was replaced daily with fresh 
media.  After one week, polymer samples were immersed in acetic acid (8 mL, 1 M) 
and sonicated for 4 h to dissolve the encrusted deposits, as previously described 
(Tunney and Gorman 2002).  The resulting solutions were filtered to remove trace 
albumin and the quantities of calcium and magnesium present on each sample 
determined by atomic absorption spectrophotometry following calibration with 
standard solutions.  Results are displayed as encrustation surface densities (μg.cm-2). 
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2.2.6.5. Microbiological assessment 
Clinical isolates of Escherichia coli were obtained from microbial biofilm present on 
retrieved ureteral stents and maintained on Müeller-Hinton agar slopes at 4°C (Keane 
et al. 1994).  Subculturing was performed at three-monthly intervals.  When required 
for the bacterial adherence assay, stationary phase E. coli was cultured by inoculating 
into Müeller-Hinton broth and incubating at 37°C in an orbital incubator (100 rpm) 
for 18 h.  The culture was then centrifuged at 3000 g for 10 min and, after discarding 
the supernatant, the resulting pellet was resuspended in sterile peptone water (0.9%) 
to an optical density equivalent to approximately 1 x 108 cfumL-1.  Polymer discs (8 
mm diameter) mounted on needles attached to lids of glass McCartney bottles were 
immersed in bacterial suspensions (20 mL) and shaken in an orbital incubator at 37°C 
for 4 h.  Following incubation, non-adherent bacteria were removed by successively 
washing the samples with sterile peptone water (3 x 5 mL).  Individual samples were 
then immersed in peptone water (10 mL), sonicated in an ultrasonic bath for 5 min 
and vortexed for 30 sec to remove adherent bacteria.  Viable counts were determined 
by the Miles and Misra drop technique on Müeller-Hinton agar and plates were 
incubated overnight at 37°C (Miles, et al. 1938). 
 
2.2.6.6. Drug loading and release 
Drug loading was achieved via the equilibrium partitioning technique.  Polymer 
samples suspended on hypodermic needles were immersed for 24 h in aqueous 
benzalkonium chloride solutions (1% w/v) saturated with ofloxacin.  Polymer-bearing 
needles were removed from the drug loading solutions, suspended in pre-heated 
buffer solutions of aqueous benzalkonium chloride (1% w/v) and shaken in an orbital 
incubator at 37°C (100rpm).  After designated time intervals, the needles were 
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transferred to fresh pre-heated buffer solutions to maintain sink conditions and the 
samples analysed by UV/Vis spectroscopy.  Respective masses of drug released were 
determined using absorbance values at 292 nm in conjugation with freshly prepared 
calibration solutions, as previously described (Irwin, et al. 2013).  Following 
completion of the release experiment, remaining ofloxacin was released by immersing 
finely divided samples in fresh buffer solutions and shaking at 37°C.  The mechanism 
of drug release from the polymers was determined by fitting data to the generalized 
power model: 
 
F = KKPtn 
 
where F represents the fractional drug release in time t, KKP is a rate constant 
incorporating geometric and structural characteristics of the release system and n is 
the release exponent used to characterize the mechanism of release (Korsmeyer, et al. 
1983; Peppas 1985). 
 
 
2.3. Statistics 
All experiments were carried out using at least three replicates and results are 
expressed as mean ± standard deviation.  Statistical analysis was performed with 
Analysis of Variance (ANOVA) software.  Post hoc comparisons of individual mean 
values were performed by the Tukey-Kramer test, with a p value <0.05 denoting 
significance. 
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3. Results and discussion 
Polymerisable derivatives of Poloxamer 188 were prepared via esterification of the 
terminal hydroxyl groups of the poloxamer moieties with methacryloyl chloride.  By 
employing a large excess of Poloxamer 188 to methacryloyl chloride, esterification at 
only one terminal position was achieved, as shown in Scheme 1. 
Alternatively, esterification at both terminal positions was achieved by employment 
of a 2:1 stoichiometric ratio of the methacryloyl chloride and poloxamer reactants, as 
shown in Scheme 2. 
 
3.1. Leaching of non-methacrylated poloxamer (NMP) from p(MMP-co-HEMA) 
copolymers 
The fraction of NMP released from the p(MMP-co-HEMA) copolymers during the 
rinsing step is shown in Figure 1.   
This graph illustrates that as the theoretical mass of poloxamer within the matrix 
increased, longer periods of time were required for the maximum levels of NMP to 
leach out of the systems (approximately 1.5 h, 2.5 h and 3.5 h for the 1%, 5% and 
10% MMP-containing copolymers respectively).  In all cases, however, significant 
fractions of NMP remained within the matrices despite prolonged periods of soaking.  
The p(MMP-co-HEMA) copolymers with weight ratios of 1%, 5% and 10% MMP 
relative to the HEMA content retained 69%, 32% and 47% of the loaded NMP within 
their matrices respectively.  This retention phenomenon was attributed to a 
combination of molecular entanglements and micellar aggregation of the NMP 
moieties with other NMP molecules and covalently-attached MMP moieties 
(Matanovic, et al. 2015).  
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3.2. Equilibrium water content 
Equilibrium water contents (EWCs) of the MMP- and DMP-containing copolymers, 
NMP-loaded p(HEMA)) and the p(HEMA) control are shown in Table 3.     
Table 3: EWCs of the synthesized polymers 
Polymer EWC (%) (Mean ± S.D.) 
p(HEMA) 58.5 ± 3.85 
NMP-loaded p(HEMA) 126.36 ± 1.03 
1% p(MMP-co-HEMA) 96.21 ± 2.49 
5% p(MMP-co-HEMA) 123.73 ± 2.24 
10% p(MMP-co-HEMA) 227.44 ± 2.84 
1% p(DMP-co-HEMA) 65.1 ± 0.94 
5% p(DMP-co-HEMA) 75.82 ± 1.05 
10% p(DMP-co-HEMA) 87.23 ± 1.74 
 
With the ability to swell and retain significant amounts of water within their networks, 
all the novel copolymers can be classed as hydrogels (Ahmed 2015).  Statistical 
differences were observed in the EWCs between all synthesized polymers, with the 
exception of 5% p(MMP-co-HEMA) and NMP-loaded p(HEMA).  The latter was 
synthesized to contain the same amount of NMP as that remaining within the matrix 
of 5% p(MMP-co-HEMA) following leaching of the non-methacrylated moiety 
during the rinsing step.  These results therefore highlight a dependency of the EWC 
on the quantity of unmodified poloxamer retained within the polymer matrix.  The 
significantly higher EWCs of the MMP- and DMP-containing copolymers than the 
p(HEMA) control furthermore highlight the higher affinity for water uptake upon 
incorporation of methacrylated poloxamer within the p(HEMA) matrix, with the 
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EWCs increasing as the percentage of methacylated poloxamer within their networks 
increased.  Moreover, comparison of the EWCs between the MMP- and DMP-
containing copolymers revealed significantly lower values for the latter polymers, as 
expected, due to the presence of NMP within the p(MMP-co-HEMA) copolymer 
matrices and the increased crosslink density of the p(DMP-co-HEMA) copolymers.  
DMP, with two terminal polymerizable groups, behaves as a crosslinker upon 
copolymerisation with 2-HEMA, restricting flexibility of the polymer chains and 
ultimately reducing the capacity for water uptake (Fu, et al. 2016).  
 
3.3. Contact angle 
The angle made by a droplet of liquid in contact with a solid surface provides a 
measure of surface water wettability (Grundke, et al. 2015).  The advancing and 
receding dynamic contact angles, formed by expansion of a droplet over a previously 
unwetted surface and retraction of a droplet from a previously wetted surface 
respectively (do Nascimento, et al. 2016; Grundke, et al. 2015), of the MMP- and 
DMP-containing copolymers, NMP-loaded p(HEMA)) and the p(HEMA) control are 
shown in Table 4.  
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Table 4: Dynamic contact angles of the synthesized polymers 
Polymer Contact Angle (°) (Mean ± S.D.) 
 Advancing Receding 
p(HEMA) 91.3 ± 1.65 92.5 ± 1.35 
NMP-loaded p(HEMA) 92.0 ± 0.700 93.0 ± 1.10 
1% p(MMP-co-HEMA) 92.0 ± 2.20 93.0 ± 2.00 
5% p(MMP-co-HEMA) 92.0 ± 0.800 93.3 ± 0.850 
10% p(MMP-co-HEMA) 98.0 ± 3.75 98.1 ± 4.75 
1% p(DMP-co-HEMA) 90.5 ± 1.15 92.3 ± 0.907 
5% p(DMP-co-HEMA) 91.8 ± 0.451 93.4 ± 0.404 
10% p(DMP-co-HEMA) 92.7 ± 1.25 94.1 ± 1.15 
 
Copolymers containing a weight ratio of 10% MMP relative to the HEMA content 
displayed significantly higher advancing contact angles than all other materials.  The 
increased contact angle indicates an increase in the hydrophobic character of the 
polymer, which is attributed to shielding of the hydrophilic moieties of the p(HEMA) 
hydrogel by comparatively more hydrophobic alkyl chains of the poloxamer moiety 
(Yuan and Lee 2013).  Receding contact angles were similar between all synthesized 
polymers, with the exception of 10% p(MMP-co-HEMA) and 1% p(DMP-co-
HEMA). 
In addition, none of the examined polymers exhibited significant contact angle 
hysteresis as a result of restricted polymer chain mobility and subsequently hindered 
molecular reorientation of surface-localized functional groups during the immersion 
process (do Nascimento, et al. 2016; Grundke, et al. 2015). 
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3.4. Tensile analysis 
The effect of copolymerization with MMP and DMP on mechanical properties of the 
polymers was herein investigated by determination of ultimate tensile strength and 
Young’s modulus of elasticity, which respectively provide a measure of polymer 
brittleness and rigidity (Kianfar, et al. 2011).  Values of ultimate tensile strength and 
Young’s modulus for the synthesized polymers are shown in Table 5. 
 
Table 5: Mechanical properties of the synthesized polymers 
Polymer Ultimate tensile strength 
(x105, Pa) (Mean ± S.D.) 
Young’s modulus of 
elasticity (x105, Pa) (Mean 
± S.D.) 
p(HEMA) 4.15 ± 1.18 9.89 ± 1.29 
NMP-loaded p(HEMA) 2.80 ± 0.423 3.87 ± 0.094 
1% p(MMP-co-HEMA) 4.32 ± 0.532 7.35 ± 0.872 
5% p(MMP-co-HEMA) 2.91 ± 0.542 3.49 ± 0.426 
10% p(MMP-co-HEMA) 1.39 ± 0.374 1.86 ± 0.195 
1% p(DMP-co-HEMA) 4.78 ± 0.399 9.49 ± 0.445 
5% p(DMP-co-HEMA) 4.57 ± 0.407 8.67 ± 0.361 
10% p(DMP-co-HEMA) 8.81 ± 2.13 10.3 ± 0.511 
 
No significant differences were observed in ultimate tensile strength between the 
synthesized polymers and the control p(HEMA), with the exception of the 10% 
MMP- and 10% DMP-containing copolymers, which displayed significantly lower 
and higher ultimate tensile strength than the p(HEMA) control respectively.  Ultimate 
tensile strength of the 10% DMP-containing copolymers was, in addition, 
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significantly higher than all other synthesized polymers, whereas the 10% MMP-
containing copolymers displayed statistically lower ultimate tensile strength than the 
materials copolymerized with DMP (1%, 5% and 10%) and 1% MMP. 
With regards to the elastic moduli, values for all MMP-containing copolymers, NMP-
loaded p(HEMA) and 5% p(DMP-co-HEMA) were significantly lower than for 
p(HEMA).  Significant differences were also observed between NMP-loaded 
p(HEMA) and all copolymers, with the exception of 5% p(MMP-co-HEMA).  
Comparison of Young’s moduli between the DMP- and MMP-containing copolymers 
revealed significantly higher values for the former materials. 
When loaded into the p(HEMA) matrix during polymerization, poloxamer moieties 
effectively act as plasticisers and ultimately reduce ultimate tensile strength and 
elastic modulus through disruption of the polymer network and distension of the 
polymer chains (Cavallari, et al. 2013).  In contrast, the significant increase in 
ultimate tensile strength upon copolymerization with a 10% weight ratio of the 
dimethacrylated moiety was expected as a result of the increased crosslink density of 
the copolymer matrix in comparison to control p(HEMA).  Crosslinking of the 
polymer matrix has previously been investigated as a strategy for improving the 
mechanical properties of hydrogels which, as a result of their high water contents and 
corresponding lower tensile strengths, are often limited in application to surface 
modification of existing devices (Jones, et al. 2005; Low, et al. 2015; Sanchez-Ferrero, 
et al. 2015).  
 
3.5. Calcium and magnesium encrustation  
Urological devices are particularly susceptible to encrustation as a result of infection 
by urease-secreting urinary pathogens such as Proteus mirabilis (Stickler and Feneley 
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2010).  The consequential elevation of urine pH leads to precipitation of crystals of 
magnesium ammonium phosphate (struvite) and calcium phosphate (hydroxyapatite) 
in the urine (Stickler and Morgan 2006).  Continued surface encrustation can 
ultimately obstruct the catheter lumen leading to urinary retention and further clinical 
complications such as pyelonephritis and septicemia (Stickler 2014).  Surface 
densities of encrusting calcium and magnesium deposits on all synthesized polymers 
following a one-week period of suspension in artificial urine are shown in Table 6. 
 
Table 6: Calcium and magnesium encrustation on synthesized polymer surfaces  
Polymer Calcium encrustation 
(surface density, μgcm-2) 
(Mean ± S.D.) 
Magnesium 
encrustation (surface 
density, μgcm-2) (Mean 
± S.D.) 
p(HEMA) 0.069 ± 0.0026 0.024 ± 0.0002 
NMP-loaded p(HEMA) 0.051 ± 0.0046 0.021 ± 0.0030 
1% p(MMP-co-HEMA) 0.036 ± 0.0042 0.017 ± 0.0020 
5% p(MMP-co-HEMA) 0.014 ± 0.0020 0.009 ± 0.0010 
10% p(MMP-co-HEMA) 0.009 ± 0.0040 0.002 ± 0.0010 
1% p(DMP-co-HEMA) 0.043 ± 0.0036 0.023 ± 0.0010 
5% p(DMP-co-HEMA) 0.021 ± 0.0030 0.019 ± 0.0020 
10% p(DMP-co-HEMA) 0.012 ± 0.0020 0.016 ± 0.0020 
 
Loading of NMP and copolymerization with the MMP and DMP moieties were found 
to significantly reduce the level of calcium encrustation with respect to the control 
p(HEMA) surface, with reductions of up to 87% reported for the 10% MMP-
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containing copolymers.  Statistically-reduced magnesium encrustation was also 
demonstrated on all copolymer surfaces relative to control p(HEMA), with the 
exception of the 1% and 5% DMP-containing copolymers.  For example, the surface 
density of magnesium deposits was approximately 92% lower on 10% p(MMP-co-
HEMA) than on p(HEMA).  Furthermore, while surfaces densities of calcium 
encrustation were observed to decrease as the weight percentage of methacrylated 
poloxamer increased, statistical analysis revealed levels of encrustation were similar 
between the MMP- and DMP-containing copolymers at each percentage loading.  
 
3.6. Bacterial adherence 
Bacterial resistance of the synthesized copolymers was herein examined by 
challenging the novel materials over a 4 h incubation period with clinical isolates of E. 
coli.  Adherence of this clinical strain to the synthesized polymers relative to the 
p(HEMA) control is reported in Table 7. 
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Table 7: Adherence of E. coli to the synthesized polymers 
Polymer Adherence of E. coli relative to 
p(HEMA) control (%) (Mean ± S.D.) 
p(HEMA) 100 ± 3.72 
NMP-loaded p(HEMA) 24.6 ± 17.9 
1% p(MMP-co-HEMA) 18.4 ± 8.04 
5% p(MMP-co-HEMA) 9.96 ± 5.88 
10% p(MMP-co-HEMA) 8.64 ± 1.44 
1% p(DMP-co-HEMA) 75.3 ± 3.48 
5% p(DMP-co-HEMA) 53.7 ± 1.08 
10% p(DMP-co-HEMA) 46.0 ± 0.240 
 
Copolymerization with the methacrylated poloxamers was demonstrated to be an 
efficacious strategy to reduce fouling by this common urinary pathogen relative to a 
commonly used hydrogel, p(HEMA), which itself has been demonstrated to give 
significant reductions in bacterial adherence in comparison with other medical device 
polymers, including silicone (Kodjikian, et al. 2002).  All copolymers displayed 
statistically lower bacterial adherence relative to control p(HEMA), with reductions in 
excess of 90% reported for 5% and 10% p(MMP-co-HEMA).  
The observed resistance to encrustation and bacterial adherence of the MMP- and 
DMP-containing copolymers in comparison to the p(HEMA) control was attributed to 
surface protrusion of the hydrophilic PEO chains of the poloxamer moieties.  
Furthermore, the reduced susceptibility to bacterial adherence, and significantly 
increased resistance to magnesium encrustation, of the MMP-containing copolymers 
in comparison to their DMP-containing counterparts was expected on account of the 
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presence of mobile chains of NMP in combination with the higher mobility of the 
PEO chains of the monomethacrylated species following copolymerization in 
comparison to the dimethacylated moieties, which are mostly crosslinked within the 
copolymer matrix.  This phenomenon, known as steric stabilization, has been widely 
reported for surface-tethered poly(ethylene glycol) chains, in which their 
conformational flexibility and large exclusion volume have been demonstrated to 
prevent macromolecular and cellular surface adhesion (Otsuka, et al. 2001).  
 
3.7. Drug release 
In addition to their non-fouling properties, the hydrophobic cores of surface-tethered 
micellar structures have been investigated for their ability to function as reservoirs 
from which controlled release of hydrophobic drugs can proceed (Otsuka, et al. 2001).  
With infection rates of up to 100% reported for urinary catheters without antibiotic 
coverage, and hospital stays prolonged by up to 25 days, efficacious strategies to 
prevent device-associated infections are urgently needed (Riley, et al. 1995).  We 
herein investigated the ability of the synthesized copolymers to control release of the 
fluoroquinolone antibiotic, ofloxacin, following loading in a saturated drug solution.  
Plots of drug release with time into 1% w/v benzalkonium solutions are shown in 
Figures 2 and 3.    
Copolymerization with MMP in weight ratios of 5% and 10% relative to the HEMA 
content and physical loading of NMP were found to significantly increase the rate of 
ofloxacin release in comparison to the p(HEMA) control, 1% p(MMP-co-HEMA) and 
the DMP-containing copolymers, as displayed in Figures 2 and 3.  Respective release 
from p(MMP-co-HEMA) copolymers with a 1%, 5% and 10% weight ratio of MMP 
after 1 h approximated 31%, 74% and 85% respectively.  In comparison to their 
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MMP-containing counterparts, release rates from the p(DMP-co-HEMA) copolymers 
were similar to p(HEMA) and release was sustained over significantly longer periods 
of time.  Respective release from copolymers containing a weight ratio of 1%, 5% and 
10% DMP after 1 h approximated 24%, 26% and 36% respectively.  Rates of water 
uptake, and resultant drug release, from hydrogels is a complex phenomenon 
governed by many factors including particle size, solubility and ionization state of the 
drug (Wen and Park 2010), pH and ionic strength of the release medium, and polymer 
characteristics including crosslink density, chemical composition, presence of 
ionisable functional groups and hydrophilicity, which in turn determine the resultant 
degree of swelling, pore interconnections and interactions with the diffusing drug 
(Hoffman 2002; Luo, et al. 2009; Sailaja, et al. 2011).  As expected, the behavior 
observed herein, namely the significantly faster rates of hydrophobic drug release 
from the 5% and 10% p(MMP-co-HEMA) copolymers and the NMP-loaded 
p(HEMA) in contrast to the more sustained release from p(HEMA), 1% p(MMP-co-
HEMA) and their p(DMP-co-HEMA) counterparts was analogous to that observed in 
the equilibrium swelling study, where the former three polymers displayed EWCs 
>100% and the latter polymers displayed EWCs <100%.  The rapid drug release from 
the polymers containing long chain NMP moieties was again attributed to their 
greater flexibility and expanded polymeric networks in contrast to the increased 
crosslink density and consequential higher rigidity of the p(DMP-co-HEMA) matrices.  
Significantly lower burst and overall rates of release from crosslinked polymers in 
comparison to uncrosslinked controls has been widely reported (Martinez, et al. 2014; 
Zhong, et al. 2015). 
Release exponents, n, which are indicative of the mechanism of release, were 
determined for all polymers by fitting release data to the power law model, F = KKPtn, 
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and are reported in Table 8 (Peppas 1985). 
 
Table 8: Release exponents for ofloxacin release from the synthesized polymers 
Polymer Release exponent n (Mean ± S.D.) 
p(HEMA) 0.32 ± 0.01 
NMP-loaded p(HEMA) 0.41 ± 0.01 
1% p(MMP-co-HEMA) 0.41 ± 0.01 
5% p(MMP-co-HEMA) 0.41 ± 0.01 
10% p(MMP-co-HEMA) 0.39 ± 0.02 
1% p(DMP-co-HEMA) 0.39 ± 0.02 
5% p(DMP-co-HEMA) 0.43 ± 0.01 
10% p(DMP-co-HEMA) 0.41 ± 0.04 
 
In all cases, release exponents were <0.5.  This deviation from the diffusional model 
of release (n = 0.5), which is characteristic of drug release from hydrated polymer 
matrices, may be attributed to further swelling of, and potential channel formation 
throughout, the polymer matrices as a result of the presence of the long alkyl chains 
of the poloxamer moiety in combination with interactions with the cationic surfactant 
benzalkonium chloride, which was added to the release medium to increase solubility 
of the hydrophobic quinolone, ofloxacin (Ivanova, et al. 2001)    
 
 
4. Conclusions 
There remains an urgent and unmet need for efficacious strategies to prevent the 
escalating global healthcare burden of catheter-associated infections.  As reported 
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herein, a combinatorial approach, namely active agent incorporation and surface 
modification, holds significant potential to achieve this goal.  Copolymerization of 
p(HEMA) with methacrylated Poloxamer 188 in a weight ratio of 10% relative to the 
HEMA content reduced surface adherence of E. coli and encrusting crystalline 
deposits by more than 90% relative to control p(HEMA).  Furthermore, these systems 
provide the additional benefit of facile tailoring of the kinetics of hydrophobic drug 
release depending on the resultant application through ready manipulation of the 
extent of poloxamer methacrylation and incorporation within the copolymer.  Faster 
release of loaded hydrophobic drug, at rates up to 16-fold higher than that from 
p(HEMA), was achieved from polymers containing NMP, whereas more sustained 
released over a period of up to four days was observed from the more highly 
crosslinked p(DMP-co-HEMA) matrices.  
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Figure Captions 
Scheme 1: Monomethacrylation of Poloxamer 188. 
Scheme 2: Dimethacrylation of Poloxamer 188. 
Figure 1: Release of NMP from the MMP-containing copolymers during the rinsing 
step. 
Figure 2: Release of ofloxacin from NMP-loaded p(HEMA) and copolymers 
containing 5% and 10% MMP. 
Figure 3: Release of ofloxacin from p(HEMA), 1% p(MMP-co-HEMA) and the 
DMP-containing copolymers. 
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